Key Takeaways
- Sequential recovery taking hold: Demand improved through Q3 after GST transition disruptions, with rural still outperforming urban but the gap narrowing to ~300 bps. Management expects Q4 to deliver high single-digit top-line growth, in line with or slightly above Q3.
- Hair oil and oral care drove the quarter: Hair oil benefited from ~100% coconut oil inflation passing through as value growth, while oral care posted double-digit growth led by the herbal/natural segment growing 500 bps ahead of non-natural.
- Premium juices reshaping the beverage mix: Activ grew 38% and coconut water ~50%, both higher-margin than nectars. Management expects this trajectory to continue, which should structurally lift portfolio margins even as Q4 remains a seasonally lower-margin quarter.
- Margin expansion story is back on the table: Management committed to returning to the erstwhile 20% operating margin, with 20%-25% of gross margin upside flowing to operating profit and the rest reinvested in advertising. Q4 EBITDA margins are expected to expand year-on-year.
- What to watch next quarter: Whether the 2% price increase flows through as planned, the pace of volume recovery now that GST transition stocks have cleared, and whether the summer season cooperates for the beverage business.
Demand Environment & Recovery
- GST disruption fading: October saw transient headwinds from the GST rate-cut transition as trade waited for new-price stocks; demand improved through the rest of Q3 and management expects sequential recovery to continue.
- Rural-urban gap narrowing: Rural continues to outperform urban but the delta has halved to ~300 bps, with urban starting to do well while rural stays consistent.
- Consumer sentiment improving: CPI inflation has been reined in, consumer confidence levels are rising, and GST rate cuts are helping sentiment. Management sees the macroeconomic environment as supportive.
- Optical depression in FMCG: Reported industry weakness is partly optical because GST rate cuts reduced pricing and value, while volumes dipped as consumers waited for new-price stocks. MAT numbers remain stable.
- Q4 top-line expectation: High single-digit growth, either in line with Q3 or a little higher, with volume growth moving up sequentially on account of GST tailwinds.
Mohit Malhotra: "Keeping our fingers crossed. I just hope the season favors us in the coming summers and the weather gods favor us. I think that is what we sit and pray."
Category Performance
| Category | Trend | Commentary |
|---|---|---|
| Hair Oil | ▲ Strong value growth | Coconut oil inflation of ~100% drove price-led value growth; volume growth muted at 3%-4% for the category. Non-coconut oils also performed well as lower LLP prices freed up margin for consumer communication. GST rate cuts provided positive upside. |
| Oral Care | ▲ Double-digit growth | Herbal/natural segment growing 500 bps ahead of non-natural. Meswak grew 25%-26%, Dabur Red toothpaste benefited from pack change and revamp. Babool not doing well, being revamped. |
| Beverages | ▼ Season-hit, mix improving | Last summer was unfavorable; old stock being liquidated to start fresh. Higher-margin Activ (+38%) and coconut water (~50%) significantly outperformed lower-margin nectars. Revenue approximately Rs. 200-odd crores. |
| Chyawanprash | ▬ Primary weak, tertiary strong | Tertiary sales up 11%, market share up on MAT basis. Primary low because last year had carry-forward stocks to liquidate, so no pre-season loading done. Q4 expected to deliver very high double-digit growth on a low base. |
| Health Juices & NPD | ▲ Strong | Health juices growing 17%-18%. Chyawanprash variants (sugar-free, Gur) growing at 2x-3x of base, contributing 13%-14% to the business. Honey variants, Shilajit resins and drops growing in very high double digits, especially on e-commerce. |
| Out-of-home (Drinks) | ▼ Weather-impacted | Impacted by unprecedented summer rains in Q1. Sequential improvement has been better, growing around 5% despite acute winters. Rs. 10-100 price points introduced to bolster seasonal impact. |
- GST benefit for beverages: The GST rate cut for juices relative to carbonated drinks has reduced the relative price index premium, which should be a helping factor for demand.
Competitive Dynamics
- Oral care intensity inching up: The main market leader has been aggressive especially in modern trade. Some abatement was visible in the previous quarter but management cannot say it will be sustained.
- Margin defense strategy: Dabur is protecting margins by saving on consumer promotions and redirecting spend into advertising. Calibrated price increases taken before GST rate cuts also helped.
- Portfolio rationalization: McKinsey was engaged and a number of tail products were rationalized, sharpening focus on core and premium SKUs.
Mohit Malhotra: "Competitive intensity in oral care has been inching up, especially in the modern trade side, with the main market leader being very aggressive on the modern trade. And of late, a bit of abatement was seen in the previous quarter, but not so much so that I can say that it is going to be sustained."
Margins & Cost Structure
- Q3 margin dynamics: Q3 is seasonally the highest EBITDA margin quarter. Q4 will be lower because glucose is salient in Q4 and it is also a juice quarter. However, year-on-year Q4 EBITDA margin expansion is expected on the back of lower inflation and a premium portfolio mix shift.
- Gross margin reinvestment formula: A significant portion of gross margin upside will be reinvested in advertising; the balance, around 20%-25% of the expansion, will flow through as operating margin expansion.
- One-time provision: A provision arising from changes in labor laws was booked this quarter.
- U.S. litigation cost: Costs have come down drastically over the past 2-3 years. Q3 saw a spike due to an insurance reimbursement creating a lower base last year. Q4 will again be on the lower side, with significant year-on-year reduction overall. Costs are expected to stabilize from next year at lower levels.
- Operating margin vs revenue: Operating margin growth will definitely be higher than revenue growth. PAT growth is expected to be higher even than operating profit growth.
Ankush Jain: "And whatever upside in gross margins we will get, a significant portion of that we may want to reinvest in advertising and balance around 20%-25% of that expansion in gross margin we will give back as operating margin expansion."
Pricing & FY27 Growth Composition
- 2% price increase in Q4: Price increases will be taken in Q4 and carried forward into next year. Pricing growth will be better compared to last year, and gross margin improvement will be better on account of pricing that was postponed due to anti-profiteering provisions during the GST transition.
- FY27 growth mix: Next year should be more volume-led given GST tailwinds, but price increases will not be absent. Pre-September price increases will have a rollover impact, and where categories face inflation, more price increases will be taken. The combination will be more volume and slightly lesser value.
- Proactive pricing stance: For brands where Dabur is the market leader, management will take price increases proactively even in a non-inflationary environment.
- FY27 top-line target: High single-digit to low double-digit growth, with operating margin improvement over the current year.
Mohit Malhotra: "We want to go back to our erstwhile 20% operating margin. So, there will be attempt to have saving initiatives and price increases even if there is no inflation."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q4 top-line growth | High single-digit growth, in line with or slightly above Q3 | Q4 FY26 |
| Q4 EBITDA margin | Year-on-year expansion, though lower than Q3 seasonally | Q4 FY26 |
| Q4 pricing | 2% price increase, carried forward into FY27 | Q4 FY26 |
| FY27 top-line growth | High single-digit to low double-digit | FY27 |
| FY27 growth composition | More volume-led, slightly lesser value; price increases not absent | FY27 |
| Operating margin target | Return to erstwhile 20% operating margin | No date (FY27 ambition) |
| Gross margin pass-through | 20%-25% of gross margin expansion flows to operating margin; rest reinvested in advertising | Ongoing |
| Beverage growth target | Double-digit growth | FY27 |
| U.S. litigation cost | Stabilize at lower levels | FY27 onwards |
| Chyawanprash Q4 growth | Very high double-digit growth on a low base | Q4 FY26 |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Consolidated revenue growth | 6.1% YoY |
| Domestic FMCG volume growth | 3% YoY |
| Operating profit growth | 7.7% YoY |
| PAT growth | 10.1% YoY; adjusted PAT growth 7.2% YoY excluding one-time labor law provision |
| Hair Oil portfolio growth | 19.1% YoY |
| Toothpaste portfolio growth | 10% YoY |
| Health supplements growth | Low single digits YoY |
| Honey growth | 10% YoY, volume-led |
| Chyawanprash offtakes growth | 11% YoY; primary sales flattish |
| Ayurvedic health juices growth | 17.9% YoY |
| Juices and Nectars market share gain | 195 bps in nectars, 650 bps in juices |
| Culinary portfolio growth | 14% YoY |
| International business growth | 11% in INR terms, 7.5% in constant currency |
| Hair oil market share gain | 193 bps; overall volume market share at all-time high of 20% |
| New product development contribution | 2% to 3% of business |